1. A80 ENDOSCOPIC HEALING WITH USTEKINUMAB IN CROHN'S DISEASE: THE UNITI ENDOSCOPY SUB-STUDY. (1st March 2018) Authors: Feagan, B G; Sandborn, W; Gasink, C; Chan, D; Lang, Y; Pollack, P; Hanauer, S; Wolf, D; Jacobstein, D; Johanns, J; Szapary, P; Rutgeerts, P Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AODWE-006 Efficacy of ustekinumab for induction and maintenance of histological healing in patient's with crohn's disease. (17th June 2017) Authors: Li, K; Chan, D; Pollack, P; Jacobstein, D; Brodmerkel, C; Gasink, C; Feagan, B; Sandborn, W; Rutgeerts, P; Hertogh, G De Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP56 Histologic disease activity correlates with endoscopic severity in patients with moderate to severe Crohn's Disease. (21st January 2022) Authors: Reinisch, W; De Hertogh, G; Protic, M; Chan, L S; Magro, F; Pollack, P; Feagan, B G; Harpaz, N; Pai, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP87 Association of histologic measurement with endoscopic outcomes after one year of treatment with mirikizumab in patients with moderate to severe Crohn's Disease. (21st January 2022) Authors: Magro, F; De Hertogh, G; Protic, M; Chan, L S; Pollack, P; Feagan, B G; Harpaz, N; Pai, R; Reinisch, W Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P395 Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn's disease. (27th May 2021) Authors: Pai, R; De Hertogh, G; Reinisch, W; Harpaz, N; Feagan, B; Agada, N; Pollack, P; Chan, L S; Protic, M; Magro, F Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗